新聞/Reuters/Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaSino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaRefinitiv閱讀少於1分鐘1177Sino Biopharmaceutical Ltd 1177:TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINAReuters中國股票亞洲香港股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
